Expert Videos

1. What is targeted therapy for lung cancer?

2. What targeted therapies are used for people with the EGFR mutation?

3. What targeted therapies are used for people with the ALK mutation?

4. What targeted therapies are used for people with the ROS1 mutation?

5. What is the importance of combination therapies for BRAF?

6. What is the future of combination therapy for lung cancer?

7. Can biomarker testing help identify clinical trial opportunities for me?

8. How can communities of color increase their participation in clinical trials?

Animation - Targeted Therapy in Non-Small Cell Lung Cancer

This animation provides an overview of targeted therapy for the treatment of non-small cell lung cancer (NSCLC). Targeted therapy is a cancer treatment directed towards specific mutations that drive cancer to grow and spread. Watch to learn about targeted therapy for common gene mutations such as EGFR, ALK, ROS1, and BRAF. You may qualify for targeted therapy based on the results of biomarker testing. This testing allows doctors to prescribe treatment that is tailored to your individual cancer. Be sure to ask your doctor about biomarker testing and targeted therapy. Targeted therapy offers hope and can make an important difference in your health outcomes.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Section: Targeted Therapy in NSCLC

Animation - Targeted Therapy in NSCLC

Slide Show - Targeted Therapy in NSCLC

Expert Videos

1. What is targeted therapy for lung cancer?

2. What targeted therapies are used for people with the EGFR mutation?

3. What targeted therapies are used for people with the ALK mutation?

4. What targeted therapies are used for people with the ROS1 mutation?

5. What is the importance of combination therapies for BRAF?

6. What is the future of combination therapy for lung cancer?

7. Can biomarker testing help identify clinical trial opportunities for me?

8. How can communities of color increase their participation in clinical trials?

Other Modules:

Treatment and Management of Lung Cancer

Immunotherapy for Lung Cancer

Understanding Non-Small Cell Lung Cancer (NSCLC)

Understanding Small Cell Lung Cancer (SCLC)

Screening for Lung Cancer

Lung Cancer Screening for Black Americans

Lung Cancer Screening for Native Americans

Diagnosis and Screening of Lung Cancer

Staging of Lung Cancer

Understanding Biomarker Testing in Non-Small Cell Lung Cancer

Understanding Clinical Trials in Lung Cancer

Lung Cancer Clinical Trials and the US Black Community

Lung Cancer Clinical Trials and Native Americans

NSCLC Treatment When You Have an EGFR Mutation

NSCLC Treatment Options When You Have an EGFR Mutation

NSCLC Treatment When You Have a KRAS Mutation

NSCLC Treatment Options When You Have a KRAS Mutation

NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET

Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Understanding Prehabilitation for Lung Cancer Surgery

Your Prehabilitation Plan for Lung Cancer Surgery

Patient Stories:

Mr. Satterfield's Story

Sharon’s Story

Terri's Story

Tricia's Story

This educational activity has been developed by A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed shared decisions, and partner with their healthcare professionals for optimal outcomes.